Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
Publication
, Journal Article
Gradishar, WJ; Anderson, BO; Abraham, J; Aft, R; Agnese, D; Allison, KH; Blair, SL; Burstein, HJ; Dang, C; Elias, AD; Giordano, SH; Goetz, MP ...
Published in: J Natl Compr Canc Netw
April 2020
Several new systemic therapy options have become available for patients with metastatic breast cancer, which have led to improvements in survival. In addition to patient and clinical factors, the treatment selection primarily depends on the tumor biology (hormone-receptor status and HER2-status). The NCCN Guidelines specific to the workup and treatment of patients with recurrent/stage IV breast cancer are discussed in this article.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
April 2020
Volume
18
Issue
4
Start / End Page
452 / 478
Location
United States
Related Subject Headings
- Recurrence
- Oncology & Carcinogenesis
- Neoplasm Staging
- Neoplasm Metastasis
- Humans
- Female
- Disease Susceptibility
- Disease Management
- Clinical Decision-Making
- Breast Neoplasms
Citation
APA
Chicago
ICMJE
MLA
NLM
Gradishar, W. J., Anderson, B. O., Abraham, J., Aft, R., Agnese, D., Allison, K. H., … Kumar, R. (2020). Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 18(4), 452–478. https://doi.org/10.6004/jnccn.2020.0016
Gradishar, William J., Benjamin O. Anderson, Jame Abraham, Rebecca Aft, Doreen Agnese, Kimberly H. Allison, Sarah L. Blair, et al. “Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw 18, no. 4 (April 2020): 452–78. https://doi.org/10.6004/jnccn.2020.0016.
Gradishar WJ, Anderson BO, Abraham J, Aft R, Agnese D, Allison KH, et al. Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 Apr;18(4):452–78.
Gradishar, William J., et al. “Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw, vol. 18, no. 4, Apr. 2020, pp. 452–78. Pubmed, doi:10.6004/jnccn.2020.0016.
Gradishar WJ, Anderson BO, Abraham J, Aft R, Agnese D, Allison KH, Blair SL, Burstein HJ, Dang C, Elias AD, Giordano SH, Goetz MP, Goldstein LJ, Isakoff SJ, Krishnamurthy J, Lyons J, Marcom PK, Matro J, Mayer IA, Moran MS, Mortimer J, O’Regan RM, Patel SA, Pierce LJ, Rugo HS, Sitapati A, Smith KL, Smith ML, Soliman H, Stringer-Reasor EM, Telli ML, Ward JH, Young JS, Burns JL, Kumar R. Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 Apr;18(4):452–478.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
April 2020
Volume
18
Issue
4
Start / End Page
452 / 478
Location
United States
Related Subject Headings
- Recurrence
- Oncology & Carcinogenesis
- Neoplasm Staging
- Neoplasm Metastasis
- Humans
- Female
- Disease Susceptibility
- Disease Management
- Clinical Decision-Making
- Breast Neoplasms